{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:28:40Z","timestamp":1789986520865,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.schres.2022.12.029","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T17:41:03Z","timestamp":1673026863000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls"],"prefix":"10.1016","volume":"252","author":[{"given":"Rose","family":"Jeppesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Christine","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina Vindegaard","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Orlovska-Waast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune Haubo Bojesen","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Eriksen","family":"Benros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2022.12.029_bb0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbi.2021.08.233","article-title":"Real-world experience of assessing antibodies against the N-methyl-D-aspartate receptor (NMDAR-IgG) in psychiatric patients. A retrospective single-Centre study","volume":"98","author":"Ari\u00f1o","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2022.12.029_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.schres.2022.12.029_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.654602","article-title":"Neural autoantibodies in cerebrospinal fluid and serum in clinical high risk for psychosis, first-episode psychosis, and healthy volunteers","volume":"12","author":"Bien","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2022.12.029_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577508","article-title":"Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis","volume":"353","author":"Broadley","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.schres.2022.12.029_bb0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000499714","article-title":"Clinically relevant anti-neuronal cell surface antibodies in schizophrenia Spectrum disorders","volume":"78","author":"Colijn","year":"2019","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2022.12.029_bb0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S2215-0366(20)30432-6","article-title":"Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies","volume":"8","author":"Cullen","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2022.12.029_bb0035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2022.12.029_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-00967-3","article-title":"Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis","volume":"10","author":"Endres","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2022.12.029_bb0045","first-page":"111","article-title":"Consensus guidelines for lumbar puncture in patients with neurological diseases","volume":"8","author":"Engelborghs","year":"2017","journal-title":"Alzheimer\u2019s Dement. Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.schres.2022.12.029_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2022.12.029_bb0055","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, neuroimmunologic, and CSF investigations in first episode psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.schres.2022.12.029_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577285","article-title":"Searching for autoimmune encephalitis: beware of normal CSF","volume":"345","author":"H\u00e9bert","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.schres.2022.12.029_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2022.12.029_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257946","article-title":"Immunological investigations of the cerebrospinal fluid in patients with recent onset psychotic disorders: a study protocol","volume":"16","author":"Jeppesen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2022.12.029_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbac098","article-title":"Cerebrospinal fluid and blood biomarkers of neuroinflammation and blood-brain barrier in psychotic disorders and individually matched healthy controls","author":"Jeppesen","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.12.029_bb0080","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in Anti\u2013 N -methyl- d -aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.schres.2022.12.029_bb0085","series-title":"The Brief Assessment of Cognition in Schizophrenia: Reliability, Sensitivity, and Comparison With a Standard Neurocognitive Battery","first-page":"283","volume":"68","author":"Keefe","year":"2004"},{"key":"10.1016\/j.schres.2022.12.029_bb0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1212\/NXI.0000000000000386","article-title":"Frequencies of neuronal autoantibodies in healthy controls estimation of disease specificity","volume":"4","author":"Lang","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.schres.2022.12.029_bb0095","article-title":"Antibodies against N-methyl D-aspartate receptor in psychotic disorders: a systematic review","volume":"1\u201318","author":"Murashko","year":"2021","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2022.12.029_bb0100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1192\/bjp.2018.24","article-title":"Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders","volume":"213","author":"Oviedo-Salcedo","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.12.029_bb0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1192\/bjp.2018.24","article-title":"Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders","volume":"212","author":"Oviedo-Salcedo","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.12.029_bb0110","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1017\/S003329171300295X","article-title":"Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis","volume":"44","author":"Pollak","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.12.029_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2022.12.029_bb0120","series-title":"R: a language and environment for statistical computing","year":"2018"},{"key":"10.1016\/j.schres.2022.12.029_bb0125","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41398-021-01701-3","article-title":"Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis","volume":"11","author":"Theorell","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2022.12.029_bb0130","series-title":"Serum and CSF Anti-NMDAR Antibody Testing in Psychiatry","first-page":"154","volume":"32","author":"Warren","year":"2019"},{"key":"10.1016\/j.schres.2022.12.029_bb0135","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses","author":"Wells","year":"2000"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422004765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422004765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:50:08Z","timestamp":1760298608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996422004765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":27,"alternative-id":["S0920996422004765"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.12.029","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}